The professor leading antitrust litigation over an alleged faculty no-poach agreement between Duke University and the University of North Carolina (UNC) persuaded a federal judge to approve a US$19 million class action settlement with Duke that builds on an earlier US$54.5 million deal.
Judge Catherine C. Eagles signed off on Monday, August 30, on the agreement, which ends the second successive lawsuit brought over the alleged no-poach pact in the US District Court for the Middle District of North Carolina. The earlier case, which settled in 2019, involved only medical faculty.
The lawsuit sought to cover a class of more than 5,000 potentially affected faculty members.
UNC settled the allegations last year in a court-approved deal in which the university agreed not to enter into no-poach deals with other employers. The university also agreed to assist Dr. Seaman in her case against Duke. It did not admit to any wrongdoing.
In the proposed settlement, Duke agreed to similar commitments as well as the US$54.5 million payment to compensate medical faculty members who allegedly were harmed. Like UNC, it did not admit to any wrongdoing as part of the settlement.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan